AHCC®  (ImmPowerTM) Immune Support

AHCC is an extract of a unique hybridization of several medical mushrooms known for their immune enhancing abilities. On their own, each mushroom has a long medical history in Japan, where their extracts are widely prescribed by physicians. But when combined into a single hybrid mushroom, the resulting active ingredient is

so potent that dozens of rigorous scientific studies have now established AHCC to be one of the world's most powerful-and safe-immune stimulators.

In vitro, animal, and human studies confirm that AHCC effectively treats, and, in some cases, even prevents the reoccurrence of liver cancer, prostate cancer, multiple myeloma, breast cancer, AIDS, and other life-threatening conditions, with no dangerous side effects. In smaller doses, AHCC can also boost the immune function of healthy people, helping to prevent infections and promote well-being.  Many health problems, including some that were previously thought to be unrelated to the immune system, are now known to result from some degree

of  immune  deficiency.  Subtle  to  severe immune dysfunction can combine with other factors to cause many

illnesses, including:

• Gum disease Recurrent infections, such as colds, flu, and parasites
• Heart disease Peptic ulcer
• Cancer Slow healing wounds
• Digestive problems AIDS
• Multiple Sclerosis Auto-immune illnesses
• Stress associated illness Chronic Fatigue Syndrome

For years, conventional medicine has tried to cope with these and other conditions as separate illnesses, often  relying on invasive and potentially dangerous disease-specific drugs, surgery, and other treatments.  Not only has this approach yielded only moderate success, in many cases it has created additional health problems: chemotherapy side effects, surgical complications, drug reactions, super-resistant bacteria, and other problems that in some cases may be as bad as (or worse than) the specific disease. In fact, according to the Journal of the American Medical Association, (v279, April 1998) prescription medications kill more than 100,000 people a year, making adverse drug reactions the fourth leading cause of death in the United States.

The cutting edge in medicine today is to shift away from disease-specific interventions and to focus on the fundamental, underlying causes of health and disease: the proper functioning of interdependent body systems, such as the nervous system, the endocrine system and the immune system.

Research Finds Remarkable Immune System Boost in Multiple Ways

Several scientific studies of the extract of AHCC, published in respected peer-reviewed journals such as International Journal of Immunology, Anti-Cancer Drugs, and Society of Natural Immunity have established the health benefits and safety of AHCC more conclusively than nearly any other natural supplement. What is especially remarkable about AHCC is that it so consistently and effectively boosts immune system function in the following ways:

• It stimulates cytokine (IL-2, IL-12, TNRα and IFNα production, which act to stimulate immune function.
• It increases NK cell activity against diseased cells as much as 300 percent.
• It increases the formation of explosive granules within NK cells. The more ammunition each NK cell carries

the more invaders it can destroy.

• It increases the number and activity of lymphocytes, specifically increasing T cells by up to 200 percent.
• It increases Interferon levels, which inhibit the replication of viruses and stimulates NK cell activity.
• It increases the formulation of TNF, a group of proteins that help destroy cancer cells.

These dramatic immune effects translate into profound health benefits. A 1995 clinical trial, published in the International Journal of Immunotherapy showed that 3 grams of AHCC per day significantly lowered the level of tumor markers (substances that detect the presence of tumors) found in patients with several different types of cancer, including prostate cancer, ovarian cancer, multiple myeloma, and breast cancer. This study documented complete remissions in six of 11 patients and significant increases in NK cell activity in nine of 11 patients. T and

B cell activity levels also rose considerably.